JOINT Corp: insider trades · United States · SEC (Form 4)

About JOINT Corp

The Joint Corp. (NASDAQ: JYNT) is a United States-based healthcare services company listed on the NASDAQ market. Its core business is the development, franchising, and operation of chiropractic clinics under the The Joint Chiropractic® brand. The company was formed on March 10, 2010, with the purpose of building a chiropractic clinic network through a franchise-led model, while at times also operating a smaller number of company-owned or managed clinics. Its headquarters are in Scottsdale, Arizona, United States. From an investment perspective, The Joint Corp. is positioned as a retail healthcare platform focused on convenience, accessibility, and standardized service delivery. The company’s model emphasizes walk-in chiropractic care and a consumer-friendly price point that management describes as below many competitors’ pricing for comparable services and often below typical insurance copay levels. This makes the business more akin to a branded local healthcare network than to a traditional provider with heavy reimbursement exposure. For French-speaking investors, the appeal lies in the blend of recurring franchise economics, brand recognition, and a potentially scalable footprint. The competitive edge of The Joint Corp. comes from its standardized clinic format, a large and expanding franchise system, and a simplified consumer value proposition. The company reports operations across numerous U.S. states, including Arkansas, California, Colorado, Florida, Illinois, Maryland, Michigan, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, and others. While its geographic reach is national, the business remains concentrated in the United States, which reduces international complexity but ties results to domestic consumer trends and local clinic execution. Recent developments have centered on refranchising and portfolio simplification. Management has been selling certain company-owned or managed clinics and redirecting resources toward a more franchise-heavy structure in order to improve profitability and reduce operational complexity. In early 2025 and again in spring 2026, the company highlighted initiatives aimed at strengthening the core business, tightening costs, and improving same-clinic performance. The Joint Corp. therefore remains a small-cap consumer healthcare franchise story, with key investment drivers including execution quality, franchise growth, same-store sales trends, and the pace at which management can translate restructuring into sustainable cash flow.